For example, in patients with ovarian cancer, those with germline variants involved in HRR are 4.3-fold more likely to develop somatic driver variants in genes strongly associated with CH, such as TP53 and PPM1D (Baranwal et al., 2022). Here, TP53 is linked to cyclic hematopoiesis.